Factors affecting the B-type natriuretic peptide levels in stroke patients

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 5, 2010, Pages 385-389

  Saritas, Ayhan ^a   Cakir, Zeynep ^a   Emet, Mucahit ^a   Uzkeser, Mustafa ^a   Akoz, Ayhan ^a   Acemoglu, Hamit ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Emergency department; Progress; Relationship

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NITROGEN; UREA;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION COEFFICIENT; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EMERGENCY CARE; FEMALE; FUNCTIONAL STATUS; GENDER; GLASGOW COMA SCALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANK SUM TEST; SINUS RHYTHM; STROKE; UREA NITROGEN BLOOD LEVEL; BLOOD; CEREBROVASCULAR ACCIDENT; COMPLICATION; EMERGENCY HEALTH SERVICE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD UREA NITROGEN; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLASGOW COMA SCALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 77953437196     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Coban O. Cerebral vessels diseases: definition, classification, epidemiology and risk factors. In: Oge E. editor. Neurology. Istanbul Faculty of Medicine Basic and Clinic Science Lesson Book. Nobel Medical Bookshop. 2004; 20:193.
2. Ogul E. Cerebral vessels diseases. Clin Neurol 2002; 1:1.
3. Duygu H, Turk U, Zoghi M, Nalbantgil S. The significance and place of plasma B-type natriuretic peptid levels in cardiovasculary diseases. Anatolian J Cardiol 2005; 5: 305-11.
4. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 2004; 20: 1245-8.
5. Schwam E. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal. Acad Emerg Med 2004; 11: 686-91.
6. Bertinchant JP. Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure. Arch Mal Coeur Vaiss 2004; 97: 881-8.
7. Osca J, Quesada A, Arnau MA, Osa A, Hervas I, Almenar L, et al. Brain natriuretic peptide. Diagnostic value in heart failure. Rev Esp Cardiol 2002; 55: 7-15.
8. Choi EY, Kwon lIM, Yoon YW, Kim D, Kim HS. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level. Yonsei Med J 2004; 45: 255-62.
9. Dimitroulas T, Giannakoulas G, Karvounis H, Gatzoulis MA, Settas L. Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension. Semin Arthritis Rheum 2009; 39: 278-84.
10. Safley DM, McCullough PA. The emerging role of brain natriuretic peptide in the management of acute and chronic heart failure in outpatients. Heart Fail Monit 2003; 4: 13-20.
11. Oppenheimer SM, Lima J. Neurology and the heart. J Neurol Neurosurg Psychiatry 1998; 64: 289-97.
12. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17: 861-4.
13. Myers MG, Norris JW, Hachinski VC, Weingert ME, Sole MJ. Cardiac sequelae of acute stroke. Stroke 1982; 13: 838-42.
14. Brosnan MJ, Clark JS, Jeffs B, Negrin CD, Van Vooren P, Arribas SM, et al. Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 1999; 33: 290-7.
15. Bulut M, Aydin SA. Stroke. In: Satar S, Karcioglu O, editors. Cardiac Emergencies. 1st ed. Adana: Nobel Bookshop, 2008: 457-80.
16. Maeda K, Tsutamota T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patient with symptomatic heart failure. Am Heart J 1998; 135: 825-32.
17. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-8.
18. Suzuki M, Hamada M, Yamamoto K, Kazatani Y, Hiwada K. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events. Hypertens Res 2002; 25: 669-76.
19. McLoan AS, Huang SJ, Nalos M, Tang B, Stewart DE. The confounding effects of age gender, serum creatinine and electrolyte concentrations in critically ill patients. Crit Care Med 2003; 31: 2611-8.
20. Estrada V, Tellez MJ, Moya J, Fernandez-Durango R, Egido J, Cruz AF. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute stroke. Am J Hypertens 1994; 7: 1085-9.
21. Eguchi K, Kario K, Shimada K, Mori T, Nii T, Ibaragi K. Circadian variation of blood pressure and neurohumoral factors during the acute phase of stroke. Clin Exp Hypertens 2002;24:109-14.
22. Nakagawa K, Yamaguchi T, Seida M, Yamada S, Imae S, Tanaka Y, et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 2005; 19: 157-64.
23. Wei T, Zeng C, Chen L, Chen Q, Zhao R, Lu G, et al. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 2005; 7: 75-9.
24. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-Type natriuretic peptide and ejection fraction for prognosis after myocardial infarction. Circulation 2003; 107: 2786-92.
25. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis 2002; 44: 293-321.
26. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-83.
27. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification ofpatients with chest pain and no ST-segment elevation. J Am Coll Card 2002; 40: 437-45.
28. Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003; 41: 1264-72.
29. McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, et al. Left ventricular dysfunction, natriuretic peptides, and mortality in urban population. Heart 2001; 86: 21-6.
30. Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997; 77: 264-7.
31. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350: 655-63.
32. Makikallio AM, Makikallio TH, Korpelainen JT, Vuolteenaho O, Tapanainen JM, Ylitalo K, et al. Natriuretic peptides and mortality after stroke. Stroke 2005; 36: 1016-20.
33. Sviri GE, Shik V, Raz B, Soustiel JF. Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochir 2003; 145: 851-60.
34. Tomita H, Metoki N, Saitoh G, Ashitate T, Echizen T, Katoh C, et al. Elevated plasma brain natriuretic peptide levels independent of heart disease in acute ischemic stroke: correlation with stroke severity. Hypertens Res 2008; 31: 1695-702.
35. Giannakoulas G, Hatzitolios A, Karvounis H, Koliakos G, Charitandi A, Dimitroulas T, et al. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 2005; 56: 723-30.